Literature DB >> 33707452

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand.

Lei Wei1, Alexander Ploss2.   

Abstract

Hepatitis B virus (HBV) is a highly contagious pathogen that afflicts over a third of the world's population, resulting in close to a million deaths annually. The formation and persistence of the HBV covalently closed circular DNA (cccDNA) is the root cause of HBV chronicity. However, the detailed molecular mechanism of cccDNA formation from relaxed circular DNA (rcDNA) remains opaque. Here we show that the minus and plus-strand lesions of HBV rcDNA require different sets of human repair factors in biochemical repair systems. We demonstrate that the plus-strand repair resembles DNA lagging strand synthesis, and requires proliferating cell nuclear antigen (PCNA), the replication factor C (RFC) complex, DNA polymerase delta (POLδ), flap endonuclease 1 (FEN-1), and DNA ligase 1 (LIG1). Only FEN-1 and LIG1 are required for the repair of the minus strand. Our findings provide a detailed mechanistic view of how HBV rcDNA is repaired to form cccDNA in biochemical repair systems.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707452     DOI: 10.1038/s41467-021-21850-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  43 in total

1.  The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis.

Authors:  G H Wang; C Seeger
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

Review 2.  New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

Authors:  Fabien Zoulim
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

3.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 4.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.

Authors:  Michael Nassal
Journal:  Gut       Date:  2015-06-05       Impact factor: 23.059

Review 5.  Hepadnavirus Genome Replication and Persistence.

Authors:  Jianming Hu; Christoph Seeger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 6.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

7.  Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand.

Authors:  W H Gerlich; W S Robinson
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

Review 8.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.

Authors:  Julie Lucifora; Ulrike Protzer
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 9.  Determinants of hepatitis B and delta virus host tropism.

Authors:  Benjamin Y Winer; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2015-07-08       Impact factor: 7.090

10.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

View more
  22 in total

1.  Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection.

Authors:  Ranjit Chauhan; Qilan Li; Molly E Woodson; Makafui Gasonoo; Marvin J Meyers; John E Tavis
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

2.  DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.

Authors:  Yingshan Chen; Yongxuan Yao; Kaitao Zhao; Canyu Liu; Yifei Yuan; Hao Sun; Dan Huang; Yi Zheng; Yuan Zhou; Jizheng Chen; Yun Wang; Chunchen Wu; Bixiang Zhang; Yujuan Guan; Feng Li; Rongjuan Pei; Xinwen Chen
Journal:  J Virol       Date:  2022-06-07       Impact factor: 6.549

3.  SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.

Authors:  Dai-Qing Wu; Qiu-Ying Ding; Na-Na Tao; Ming Tan; Yuan Zhang; Fan Li; Yu-Jiao Zhou; Mei-Ling Dong; Sheng-Tao Cheng; Fang Ren; Juan Chen; Ji-Hua Ren
Journal:  Front Microbiol       Date:  2022-05-19       Impact factor: 6.064

4.  Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

Authors:  Sreya Biswas; Lauren N Rust; Jochen M Wettengel; Sofiya Yusova; Miranda Fischer; Julien N Carson; Josie Johnson; Lei Wei; Trason Thode; Mohan R Kaadige; Sunil Sharma; Majd Agbaria; Benjamin N Bimber; Thomas Tu; Ulrike Protzer; Alexander Ploss; Jeremy V Smedley; Gershon Golomb; Jonah B Sacha; Benjamin J Burwitz
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

5.  Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.

Authors:  Alexander L Marchetti; Hu Zhang; Elena S Kim; Xiaoyang Yu; Sunbok Jang; Mu Wang; Haitao Guo
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

Review 6.  Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation.

Authors:  João Diogo Dias; Nazim Sarica; Christine Neuveut
Journal:  Viruses       Date:  2021-04-26       Impact factor: 5.048

7.  A Simple and Rapid Method for Quantitative Detection of Hepatitis B Virus Drug-resistant Mutations.

Authors:  Ran Wang; Zhengde Xie
Journal:  J Clin Transl Hepatol       Date:  2021-04-16

Review 8.  Hepatitis B virus-host interactions and novel targets for viral cure.

Authors:  Gaëtan Ligat; Eloi R Verrier; Michael Nassal; Thomas F Baumert
Journal:  Curr Opin Virol       Date:  2021-05-22       Impact factor: 7.121

Review 9.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

Review 10.  In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?

Authors:  Katja Giersch; Maura Dandri
Journal:  Viruses       Date:  2021-03-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.